Global Transplant Diagnostics Market Forecast to 2025 - CAGR of 7.2% Expected During the Forecast Period - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Transplant Diagnostics Market by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent, Software), Application (HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Bone Marrow), End User (Hospital) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The transplant diagnostics market is expected to reach USD 5.5 billion by 2025 from USD 3.6 billion in 2019, at a CAGR of 7.2%.

The demand for transplant diagnostic products is expected to grow due to technological advancements in the field of transplant diagnostics and increasing public-private funding for target research activities. The transplant diagnostics market is segmented on product, technology, application, transplant type, end user, and region.

The independent reference laboratories segment accounted for the largest share of the transplant diagnostics market, by end user, in 2019.

Based on end user, the transplant diagnostics market is segmented into independent reference laboratories, hospitals & transplant centers, and research laboratories & academic institutes. In 2019, independent reference laboratories accounted for the largest share of the transplant diagnostics market due to rapid modernization and automation in diagnostic laboratories, the growing number of R&D activities outsourced by pharmaceutical & biotechnology companies to independent reference laboratories.

The molecular assay technologies segment accounted for the largest share of the transplant diagnostics market, by technology, in 2019.

The transplant diagnostics market, by technology, is segmented into molecular (PCR-based assay and sequencing-based assay technologies) and non-molecular assay technologies. In 2019, the molecular assay technologies segment accounted for the largest share of the transplant diagnostics market due to the benefits of molecular assays such as low turnaround times, high procedural efficacy, and real-time sample analysis.

North America accounted for the largest share of the transplant diagnostics market in 2019.

North America accounted for the largest share of the transplant diagnostics market in 2019, followed by Europe. This can primarily be attributed to the wide availability of advanced transplant diagnostic technologies, well-established distribution channels, and significant public awareness about the clinical benefits of diagnostic products in risk assessment for donors and recipients during transplantations.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

4.1 Transplant Diagnostics Market Overview

4.2 Market, By Technology

4.3 Regional Analysis: Market, By Application

4.4 Asia Pacific: Market, By End User, 2019

4.5 Regional Analysis: Market, By Product & Service

4.6 Regional Analysis: Market, By Transplant Type

4.7 Market, By Country

5 Market Overview

5.1 Introduction

5.2 Market Dynamics

5.2.1 Key Market Drivers

5.2.1.1 Increasing Number of Transplant Procedures

5.2.1.2 Technological Advancements in the Field of Transplant Diagnostics

5.2.1.3 Increasing Public-Private Funding for Target Research Activities

5.2.1.4 Increasing Prevalence of Infectious Diseases

5.2.2 Key Market Restraints

5.2.2.1 High Procedural Cost of Ngs- and Pcr-Based Diagnostic Assays

5.2.2.2 Limited Reimbursements for Target Procedures

5.2.3 Key Market Opportunities

5.2.3.1 Rising Adoption of Cross-Matching and Chimerism Testing During Pre- & Post-Transplantation

5.2.3.2 Growing Public Awareness About Organ Donation and Transplantation

5.2.4 Key Market Challenges

5.2.4.1 Significant Gap Between the Number of Organ Donors and Organs Required Annually

5.2.4.2 Procedural and Technical Limitations Associated With Donor-Recipient Screening

6 Transplant Diagnostics Market, By Technology

6.1 Introduction

6.2 Molecular Assay Technologies

6.2.1 Pcr-Based Molecular Assays

6.2.1.1 Sequence-Specific Oligonucleotide-Pcr

6.2.1.1.1 Sso-Pcr is the Most Widely Adopted Technique in the Pcr-Based Molecular Assays Market

6.2.1.2 Sequence-Specific Primer-Pcr

6.2.1.2.1 Growing Public-Private Investments for Research Activities to Support Market Growth

6.2.1.3 Real-Time Pcr

6.2.1.3.1 Real-Time Pcr Requires Smaller Sample Volumes As Compared to Conventional Pcr Technologies

6.2.1.4 Other Pcr-Based Molecular Assays

6.2.2 Sequencing-Based Molecular Assays

6.2.2.1 Sanger Sequencing

6.2.2.1.1 Sanger Sequencing Segment to Register the Highest Growth in the Sequencing-Based Molecular Assays Market

6.2.2.2 Next-Generation Sequencing

6.2.2.2.1 Low Turnaround Time & High Throughput Sequencing are the Major Factors Supporting the Adoption of Ngs

6.2.2.3 Other Sequencing-Based Molecular Assays

6.3 Non-Molecular Assay Technologies

6.3.1 Replacement of Non-Molecular Assay Techniques With Dna-Based Techniques is Expected to Hamper Market Growth

7 Transplant Diagnostics Market, By Product & Service

8 Transplant Diagnostics Market, By Application

9 Transplant Diagnostics Market, By Transplant Type

9.1 Introduction

9.2 Solid Organ Transplantation

9.2.1 Kidney Transplantation

9.2.1.1 Market Growth is Mainly Driven By Rising Kidney Disease Prevalence

9.2.2 Liver Transplantation

9.2.3 Lung Transplantation

9.2.4 Heart Transplantation

9.2.5 Pancreas Transplantation

9.2.6 Other Organ Transplantations

9.3 Stem Cell Transplantation

9.4 Soft Tissue Transplantation

9.5 Bone Marrow Transplantation

9.5.1 Dearth of Well-Trained Surgeons to Perform Bone Marrow Transplantation is Expected to Hinder Market Growth

10 Transplant Diagnostics Market, By End User

10.1 Introduction

10.2 Independent Reference Laboratories

10.2.1 Rising Consolidation of Diagnostic Laboratories to Drive Market Growth

10.3 Hospitals & Transplant Centers

10.3.1 Growing Purchasing Power of Hospitals & Transplant Centers has Resulted in High Market Growth

10.4 Research Laboratories & Academic Institutes

10.4.1 Growing Awareness About the Genetic Techniques in Transplant Rejection Monitoring to Drive Market Growth

11 Transplant Diagnostics Market, By Region

11.1 Introduction

11.2 North America

11.2.1 US

11.2.1.1 Ongoing Technological Advancements in the Field of Transplant Diagnostics to Drive Market Growth in the US

11.2.2 Canada

11.2.2.1 Growing Availability of Transplant Diagnostic Products to Support Market Growth in Canada

11.3 Europe

11.4 Asia Pacific

11.5 Latin America

11.6 Middle East & Africa

12 Competitive Landscape

12.1 Overview

12.2 Market Share Analysis

12.3 Competitive Scenario

12.3.1 Product Launches & Enhancements

12.3.2 Agreements, Partnerships, and Collaborations

12.3.3 Acquisitions

12.3.4 Expansions

12.4 Competitive Leadership Mapping

12.4.1 Visionary Leaders

12.4.2 Innovators

12.4.3 Dynamic Differentiators

12.4.4 Emerging Companies

13 Company Profiles

13.1 Becton, Dickinson and Company

13.2 Biofortuna

13.3 Biomrieux SA

13.4 Bio-Rad Laboratories

13.5 Caredx

13.6 F. Hoffman-La Roche Limited

13.7 Gendx

13.8 Hologic, Inc.

13.9 Illumina, Inc.

13.10 Immucor, Inc.

13.11 Luminex Corporation

13.12 Merck KGaA

13.13 Omixon

13.14 Qiagen Nv

13.15 Thermo Fisher Scientific

13.16 Emerging Players

13.16.1 Alpha Biotech, Ltd.

13.16.2 Bag Healthcare

13.16.3 Hansa Biopharma AB

13.16.4 Histogenetics LLC

13.16.5 Pacific Biosciences of California, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/jyrmyh